Editorial: Adopting drug repurposing to overcome drug resistance in cancer

Bibliographic Details
Main Authors: Eswar Shankar, Vish Subramaniam, Dharmaraja Allimuthu
Format: Article
Language:English
Published: Frontiers Media S.A. 2023-04-01
Series:Frontiers in Cell and Developmental Biology
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fcell.2023.1191682/full
_version_ 1797837839416688640
author Eswar Shankar
Vish Subramaniam
Vish Subramaniam
Dharmaraja Allimuthu
author_facet Eswar Shankar
Vish Subramaniam
Vish Subramaniam
Dharmaraja Allimuthu
author_sort Eswar Shankar
collection DOAJ
first_indexed 2024-04-09T15:32:12Z
format Article
id doaj.art-58b5e85d64544f69b8056045226fc69a
institution Directory Open Access Journal
issn 2296-634X
language English
last_indexed 2024-04-09T15:32:12Z
publishDate 2023-04-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Cell and Developmental Biology
spelling doaj.art-58b5e85d64544f69b8056045226fc69a2023-04-28T05:55:40ZengFrontiers Media S.A.Frontiers in Cell and Developmental Biology2296-634X2023-04-011110.3389/fcell.2023.11916821191682Editorial: Adopting drug repurposing to overcome drug resistance in cancerEswar Shankar0Vish Subramaniam1Vish Subramaniam2Dharmaraja Allimuthu3Department of Internal Medicine, Division of Medical Oncology, The Ohio State University Comprehensive Cancer Center, Columbus, OH, United StatesDepartment of Internal Medicine, Division of Medical Oncology, The Ohio State University Comprehensive Cancer Center, Columbus, OH, United StatesDepartment of Mechanical and Aerospace Engineering, The Ohio State University, Columbus, OH, United StatesDepartment of Chemistry, Indian Institute of Technology Kanpur, Kanpur, Uttar Pradesh, Indiahttps://www.frontiersin.org/articles/10.3389/fcell.2023.1191682/fullcancer drug resistancedrug repurposingFDA-approved drugsnatural productcombination therapy
spellingShingle Eswar Shankar
Vish Subramaniam
Vish Subramaniam
Dharmaraja Allimuthu
Editorial: Adopting drug repurposing to overcome drug resistance in cancer
Frontiers in Cell and Developmental Biology
cancer drug resistance
drug repurposing
FDA-approved drugs
natural product
combination therapy
title Editorial: Adopting drug repurposing to overcome drug resistance in cancer
title_full Editorial: Adopting drug repurposing to overcome drug resistance in cancer
title_fullStr Editorial: Adopting drug repurposing to overcome drug resistance in cancer
title_full_unstemmed Editorial: Adopting drug repurposing to overcome drug resistance in cancer
title_short Editorial: Adopting drug repurposing to overcome drug resistance in cancer
title_sort editorial adopting drug repurposing to overcome drug resistance in cancer
topic cancer drug resistance
drug repurposing
FDA-approved drugs
natural product
combination therapy
url https://www.frontiersin.org/articles/10.3389/fcell.2023.1191682/full
work_keys_str_mv AT eswarshankar editorialadoptingdrugrepurposingtoovercomedrugresistanceincancer
AT vishsubramaniam editorialadoptingdrugrepurposingtoovercomedrugresistanceincancer
AT vishsubramaniam editorialadoptingdrugrepurposingtoovercomedrugresistanceincancer
AT dharmarajaallimuthu editorialadoptingdrugrepurposingtoovercomedrugresistanceincancer